De Pu Shi (Hangzhou) Biotechnology

DPS Biotechnology is a high-tech medical device company based in Hangzhou, China, specializing in the development and manufacturing of advanced interventional medical products. The company focuses on minimally invasive solutions for neurovascular, cardiovascular, and peripheral vascular diseases. Its product portfolio includes NMPA-approved devices such as embolization coils, microcatheters, and balloon dilatation catheters. DPS Biotechnology leverages a strong research and development foundation to provide high-quality, domestically produced alternatives to imported high-end medical consumables. The firm is backed by prominent investors including Sequoia China and HighLight Capital, positioning it as a key player in China's vascular intervention market.